Literature DB >> 26123439

Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma.

Florence Mauger1, Cécile Dulary, Christian Daviaud, Jean-François Deleuze, Jorg Tost.   

Abstract

Circulating cell-free DNA (ccfDNA) has great potential for non-invasive diagnostics, and prediction and monitoring of treatment response, but its amount is usually limited. Therefore, the choice of methods to extract and characterize ccfDNA is crucial. In the current study, we performed the most comprehensive comparison of methods for ccfDNA extraction (11 methods), quantification (3 methods), and estimation of the integrity index (2 methods) from small quantities of different kinds of plasma. The QIAamp® Circulating Nucleic Acid Kit and the Norgen Plasma/Serum Circulating DNA Purification Mini Kit showed the best accuracy and reproducibility, but the Norgen kit allowed to extract a higher amount of ccfDNA. This workflow provides a reliable protocol for the multiple applications of ccfDNA in biomedicine.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26123439     DOI: 10.1007/s00216-015-8846-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  33 in total

1.  Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics.

Authors:  Hoyoon Lee; Chanhee Park; Wonhwi Na; Kyong Hwa Park; Sehyun Shin
Journal:  NPJ Precis Oncol       Date:  2020-02-24

Review 2.  Methylation analyses in liquid biopsy.

Authors:  Delphine Lissa; Ana I Robles
Journal:  Transl Lung Cancer Res       Date:  2016-10

Review 3.  Molecular Profiling of Liquid Biopsy Samples for Precision Medicine.

Authors:  Camila D M Campos; Joshua M Jackson; Małgorzata A Witek; Steven A Soper
Journal:  Cancer J       Date:  2018 Mar/Apr       Impact factor: 3.360

4.  Quantitative analysis of individual cell-free DNA concentration before and after penetrating trauma.

Authors:  Katrin Brodbeck; Stefanie Kern; Sylvia Schick; Arnd Steinbrück; Michael Schwerer; Birgit Bayer; Katja Anslinger; Steffen Peldschus
Journal:  Int J Legal Med       Date:  2018-10-16       Impact factor: 2.686

5.  Methods for the Detection of Circulating Biomarkers in Cancer Patients.

Authors:  Patricia Mondelo-Macía; Ana María Rodríguez-Ces; María Mercedes Suárez-Cunqueiro; Laura Muinelo Romay
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  Microfluidic-based solid phase extraction of cell free DNA.

Authors:  Camila D M Campos; Sachindra S T Gamage; Joshua M Jackson; Malgorzata A Witek; Daniel S Park; Michael C Murphy; Andrew K Godwin; Steven A Soper
Journal:  Lab Chip       Date:  2018-11-06       Impact factor: 6.799

7.  Enhanced-ice-COLD-PCR for the Sensitive Detection of Rare DNA Methylation Patterns in Liquid Biopsies.

Authors:  Florence Mauger; Jörg Tost
Journal:  Bio Protoc       Date:  2019-12-05

Review 8.  Role of Circulating Tumor DNA in Hematological Malignancy.

Authors:  Miho Ogawa; Kazuaki Yokoyama; Seiya Imoto; Arinobu Tojo
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

Review 9.  Ischemia-Reperfusion Injuries Assessment during Pancreas Preservation.

Authors:  Thomas Prudhomme; John F Mulvey; Liam A J Young; Benoit Mesnard; Maria Letizia Lo Faro; Ann Etohan Ogbemudia; Fungai Dengu; Peter J Friend; Rutger Ploeg; James P Hunter; Julien Branchereau
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

Review 10.  Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic.

Authors:  Alessia Cimadamore; Liang Cheng; Francesco Massari; Matteo Santoni; Laura Pepi; Carmine Franzese; Marina Scarpelli; Antonio Lopez-Beltran; Andrea Benedetto Galosi; Rodolfo Montironi
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.